Yingqian Zhan

12PUBLICATIONS
72CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 05, 2024
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis.

Xueqian Zhuang, Qing Wang, Simon Joost

|Nov 02, 2024
ChromaFold predicts the 3D contact map from single-cell chromatin accessibility.

Vianne R Gao, Rui Yang, Arnav Das

|Sep 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer.

Hirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi

|Jul 25, 2024
CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation.

Alvaro Quintanal-Villalonga, Kenta Kawasaki, Esther Redin

|Aug 02, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.

Alvaro Quintanal-Villalonga, Vidushi Durani, Amin Sabet

|Feb 09, 2023
TET2 guards against unchecked BATF3-induced CAR T cell expansion.

Nayan Jain, Zeguo Zhao, Judith Feucht

Pageof 2

Frequent Collaborators

5 joint publications

Richard P Koche

4 joint publications

Charles M Rudin

3 joint publications

Umeshkumar K Bhanot

3 joint publications

Christina S Leslie